Timothy E Egbo
Overview
Explore the profile of Timothy E Egbo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Egbo T, Blancett C, Payne J, Stefan C, Minogue T, Sellers J, et al.
BMC Infect Dis
. 2025 Jan;
25(1):63.
PMID: 39810089
Background: Point of need diagnostics provide efficient testing capability for remote or austere locations, decreasing the time to answer by minimizing travel or sample transport requirements. Loop-mediated isothermal amplification (LAMP)...
2.
Okore W, Ouma C, Okoth R, Yeda R, Ingasia L, Mwakio E, et al.
PLoS One
. 2024 Jun;
19(6):e0298585.
PMID: 38900782
Single nucleotide polymorphisms (SNPs) in the Plasmodium falciparum multi-drug resistance protein 1 (Pfmrp1) gene have previously been reported to confer resistance to Artemisinin-based Combination Therapies (ACTs) in Southeast Asia. A...
3.
Sahu R, Verma R, Egbo T, Giambartolomei G, Singh S, Dennis V
Pathog Dis
. 2024 Jun;
82.
PMID: 38862192
To begin to optimize the immunization routes for our reported PLGA-rMOMP nanovaccine [PLGA-encapsulated Chlamydia muridarum (Cm) recombinant major outer membrane protein (rMOMP)], we compared two prime-boost immunization strategies [subcutaneous (SC)...
4.
Amwoma J, Kituyi S, Wakoli D, Ochora D, Chemwor G, Maisiba R, et al.
Biochem Biophys Rep
. 2023 Dec;
37:101596.
PMID: 38146350
The molecular mechanism underlying persistence in the asymptomatic phase of infection remains largely unknown. However, large-scale shifts in the parasites' gene expression during asymptomatic infections may enhance phenotypic plasticity, maximizing...
5.
Chemwor G, Andagalu B, Onyango I, Opot B, Okoth R, Yedah R, et al.
Int J Infect Dis
. 2023 Apr;
132:17-25.
PMID: 37061211
Objectives: This study examined the treatment response of mixed vs single-species Plasmodium falciparum infections to artemisinin-based combination therapies (ACTs). Methods: A total of 1211 blood samples collected on days 0,...
6.
Verma R, Sahu R, Singh D, Egbo T
Semin Cell Dev Biol
. 2019 Apr;
96:44-52.
PMID: 30986568
The latest breakthrough towards the adequate and decisive methods of gene editing tools provided by CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeat/CRISPR Associated System), has been repurposed into a tool...